Yujie Yan

Title: Yujie Yan: Innovator in Bispecific Antibody Development

Introduction

Yujie Yan is a notable inventor based in China, recognized for his contributions to the field of biopharmaceuticals. His innovative work focuses on the development of bispecific antibodies, which have significant implications for cancer treatment.

Latest Patents

Yujie Yan holds a patent titled "Homodimeric Bispecific Antibody, Preparation Method Therefor And Use Thereof." This invention provides a tetravalent homodimeric bispecific antibody molecule that targets both an immune effector cell antigen, CD3, and a tumor-associated antigen. The bispecific antibody molecule is structured to include a first single chain Fv, a second single chain Fv, and an Fc fragment. The first single chain Fv specifically binds to the tumor-associated antigen, while the second single chain Fv binds to CD3. The two single chain Fvs are connected by a linker peptide, and the Fc fragment is designed without effector functions such as CDC, ADCC, and ADCP.

Career Highlights

Yujie Yan is currently employed at Ampsource Biopharma Shanghai Inc., where he continues to advance his research in bispecific antibodies. His work is pivotal in the development of novel therapeutic strategies for cancer treatment.

Collaborations

Yujie collaborates with talented colleagues, including Qiang Li and Xinlu Ma, who contribute to the innovative environment at Ampsource Biopharma Shanghai Inc.

Conclusion

Yujie Yan's work in bispecific antibody development represents a significant advancement in biopharmaceutical innovation. His contributions are expected to have a lasting impact on cancer therapies and treatment methodologies.